Home NDC 61079-025 bB Medicated Pain Relieving Oil
Product NDC 61079-025
11-digit product format 610790025
Labeler code 61079
Product ID 61079-025_0bc4e3b7-24a6-435a-e054-00144ff88e88
Type HUMAN OTC DRUG
Nonproprietary name bB Medicated Pain Relieving Oil
Dosage form OIL
Route PERCUTANEOUS; TOPICAL; TRANSDERMAL
Labeler BB BIOCHEM LABORATORIES, INC.
Application part348
Marketing category OTC MONOGRAPH NOT FINAL
Marketing start 2014-11-01
Marketing end 0000-00-00
Substance CAMPHOR (SYNTHETIC); LEVOMENTHOL; METHYL SALICYLATE; EUCALYPTUS OIL; CAPSAICIN
Active strength 3 g/100g; g/100g; g/100g; g/100g; g/100g
NDC exclude flag E
Listing certified through 2018-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 44 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 61079-025-13 I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 61079-025-13 I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 61079-025-13 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 61079-025-13 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 61079-025-13 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 61079-025-13 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 61079-025-13 I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 61079-025-13 I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 61079-025-13 I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 61079-025-13 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 61079-025-13 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 61079-025-13 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 61079-025-13 I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product I Inactivated by FDA 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 61079-025-13 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 61079-025-13 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 61079-025-13 I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 61079-025-13 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product I Inactivated by FDA bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 61079-025-13 I Inactivated by FDA bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 excluded product product I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 61079-025-13 I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2020-12-18 03:04 UTC · source 2020-12-17 excluded product product I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 61079-025-13 I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 excluded product product I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 61079-025-13 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2019-12-08 06:16 UTC · source 2019-12-05 excluded product product E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 61079-025-13 E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 61079-025-13 bB Medicated Pain Relieving Oil 13 g in 1 BOTTLE, GLASS OIL 13 8
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded CAMPHOR (NATURAL) ACTIVE INGREDIENT N20HL7Q941 BB MEDICATED PAIN RELIEVING OIL OIL [BB BIOCHEM LABORATORIES, INC.] 8 CAMPHOR (SYNTHETIC) ACTIVE INGREDIENT 5TJD82A1ET BB MEDICATED PAIN RELIEVING OIL OIL [BB BIOCHEM LABORATORIES, INC.] 8 CAPSAICIN ACTIVE INGREDIENT S07O44R1ZM BB MEDICATED PAIN RELIEVING OIL OIL [BB BIOCHEM LABORATORIES, INC.] 8 EUCALYPTUS OIL ACTIVE INGREDIENT 2R04ONI662 BB MEDICATED PAIN RELIEVING OIL OIL [BB BIOCHEM LABORATORIES, INC.] 8 LEVOMENTHOL ACTIVE INGREDIENT BZ1R15MTK7 BB MEDICATED PAIN RELIEVING OIL OIL [BB BIOCHEM LABORATORIES, INC.] 8 METHYL SALICYLATE ACTIVE INGREDIENT LAV5U5022Y BB MEDICATED PAIN RELIEVING OIL OIL [BB BIOCHEM LABORATORIES, INC.] 8 CAMPHOR (NATURAL) ACTIVE MOIETY N20HL7Q941 BB MEDICATED PAIN RELIEVING OIL OIL [BB BIOCHEM LABORATORIES, INC.] 8 CAMPHOR (SYNTHETIC) ACTIVE MOIETY 5TJD82A1ET BB MEDICATED PAIN RELIEVING OIL OIL [BB BIOCHEM LABORATORIES, INC.] 8 CAPSAICIN ACTIVE MOIETY S07O44R1ZM BB MEDICATED PAIN RELIEVING OIL OIL [BB BIOCHEM LABORATORIES, INC.] 8 EUCALYPTUS OIL ACTIVE MOIETY 2R04ONI662 BB MEDICATED PAIN RELIEVING OIL OIL [BB BIOCHEM LABORATORIES, INC.] 8 LEVOMENTHOL ACTIVE MOIETY BZ1R15MTK7 BB MEDICATED PAIN RELIEVING OIL OIL [BB BIOCHEM LABORATORIES, INC.] 8 SALICYLIC ACID ACTIVE MOIETY O414PZ4LPZ BB MEDICATED PAIN RELIEVING OIL OIL [BB BIOCHEM LABORATORIES, INC.] 8 ALCOHOL INACTIVE INGREDIENT 3K9958V90M BB MEDICATED PAIN RELIEVING OIL OIL [BB BIOCHEM LABORATORIES, INC.] 8 CETYL ALCOHOL INACTIVE INGREDIENT 936JST6JCN BB MEDICATED PAIN RELIEVING OIL OIL [BB BIOCHEM LABORATORIES, INC.] 8 ISOPROPYL MYRISTATE INACTIVE INGREDIENT 0RE8K4LNJS BB MEDICATED PAIN RELIEVING OIL OIL [BB BIOCHEM LABORATORIES, INC.] 8 POLYSORBATE 80 INACTIVE INGREDIENT 6OZP39ZG8H BB MEDICATED PAIN RELIEVING OIL OIL [BB BIOCHEM LABORATORIES, INC.] 8 SORBITAN MONOLAURATE INACTIVE INGREDIENT 6W9PS8B71J BB MEDICATED PAIN RELIEVING OIL OIL [BB BIOCHEM LABORATORIES, INC.] 8 WATER INACTIVE INGREDIENT 059QF0KO0R BB MEDICATED PAIN RELIEVING OIL OIL [BB BIOCHEM LABORATORIES, INC.] 8
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 61079-025 BB MEDICATED PAIN RELIEVING OIL OIL [BB BIOCHEM LABORATORIES, INC.] 8 Legacy NDC, 1 package rows 20150105_07b43c31-a4d2-5c29-e054-00144ff88e88.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Status 61079-025-13 61079002513 13 g in 1 BOTTLE, GLASS 13 g Historical